PROFUND ADVISORS LLC

Position in RCUS — Arcus Biosciences, Inc.

CIK 1129919 BETHESDA, MD

Position in RCUS

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$1,169,920

+$225,323 QoQ

Shares Held

54,163

+36.6% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $183,565,563 across 158 Biotechnology names. RCUS ranks #63 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,137	$10,331,595
2	REGN	Regeneron Pharmaceuticals, Inc.	10,332	$7,982,916
3	ALNY	Alnylam Pharmaceuticals, Inc.	14,647	$4,846,252
4	INSM	INSMED Inc	27,937	$4,568,258
5	APLS	Apellis Pharmaceuticals, Inc.	81,190	$3,266,273
6	MDGL	Madrigal Pharmaceuticals, Inc.	4,862	$2,545,111
7	TGTX	Tg Therapeutics, Inc.	76,039	$2,526,015
8	ARWR	Arrowhead Pharmaceuticals, Inc.	39,758	$2,492,826

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,169,920	54,163	+36.6%	Shares	Sole	2026-04-27
2025-12-31	$944,597	39,639	+125.3%	Shares	Sole	2026-02-06
2025-09-30	$239,237	17,591	-23.7%	Shares	Sole	2025-11-06
2025-06-30	$187,789	23,070	-8.3%	Shares	Sole	2025-08-07
2025-03-31	$197,490	25,158	+46.9%	Shares	Sole	2025-05-08
2024-12-31	$254,931	17,121	-8.5%	Shares	Sole	2025-02-14
2024-09-30	$286,228	18,720	-5.2%	Shares	Sole	2024-11-14
2024-06-30	$300,594	19,737	-63.7%	Shares	Sole	2024-08-13
2024-03-31	$1,027,638	54,430	+26.1%	Shares	Sole	2024-05-08
2023-12-31	$824,451	43,165	-15.5%	Shares	Sole	2024-02-14
2023-09-30	$916,724	51,071	-9.4%	Shares	Sole	2023-11-13
2023-06-30	$1,145,402	56,396	-27.5%	Shares	Sole	2023-08-10
2023-03-31	$1,418,561	77,772	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.